Lallemand Health Solutions and dsm-firmenich are partnering to launch new synergistic synbiotic solutions combining human milk oligosaccharides (HMOs) and probiotics for for early-life nutrition.
A probiotic strain marketed by Lallemand Health Solutions has been granted new health claims related to Irritable Bowel Syndrome (IBS) by Canadian health authority Health Canada.
More studies looking at the link between a human’s microbiome and depression are underway. It’s not entirely a novel connection, according to Dr. Thomas Tompkins, research director at Lallemand Health Solutions, and there’s opportunity for probiotics...
The market for probiotic supplements and food continues to grow at a fast clip worldwide, expected to reach $45bn by 2017 (up from $30bn in 2012), according to Euromonitor. Global ingredient supplier Lallemand Health Solutions is no stranger to this market,...